Table 1.

Clinical characteristics of nAMD patients and controls.

Characteristic	nAMD patients (n = 21)	Control (n = 17)	P value
Age (year)	69.0 ± 10.2* (48 ∼ 8)	73.7 ± 9.43 (56 ∼ 90)	0.12
Gender (M/F)	15/6	6/11	0.06
phenotypes
CNV Type I	4 (19†)
CNV Type II	9 (43)
PCV	8 (38)
RAP	0 (0)

nAMD: Neovascular age-related macular degeneration. CNV: Choroidal neovascularization. PCV: Polypoidal choroidal vasculopathy. RAP: Retinal angiomatous proliferation. *Mean ± standard deviation (range). ^†Percentage.